SCHEMBL7728192

SCHEMBL7728192

CC(C)(C)OC(=O)N1C[C@H](N(C(=O)CN)C(=O)OC(C)(C)C)C[C@H]1C(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
NPC1 O15118 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
ABL1 P00519 5/20 0.40
BCR P11274 5/20 0.40
HDAC8 Q9BY41 7/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PTPN2 P17706 1/20 0.38
PTPN1 P18031 1/20 0.38
PTPN6 P29350 1/20 0.38
P2RX3 P56373 1/20 0.38
F10 P00742 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7727754 0.96 POLB (0.44) POLBNPC1CYP1A2CYP3A4CYP2C19
SCHEMBL7725709 0.91 NPC1 (0.43) POLBNPC1CYP1A2CYP3A4CYP2C19
SCHEMBL7731725 0.89 HDAC8 (0.44) POLBNPC1CYP1A2CYP3A4CYP2C19
SCHEMBL7726523 0.88 HDAC8 (0.41) POLBNPC1CYP1A2CYP3A4CYP2C19
SCHEMBL7731479 0.88 HDAC8 (0.44) POLBNPC1CYP1A2CYP3A4CYP2C19
SCHEMBL7727252 0.85 KDM4E (0.46) POLBNPC1HDAC8ALDH1A1
SCHEMBL7721906 0.82 USP30 (0.39) POLBCYP1A2CYP3A4CYP2C19ABL1
SCHEMBL7729236 0.81 HDAC4 (0.41) POLBNPC1CYP1A2CYP3A4CYP2C19
SCHEMBL7730697 0.80 SMN1; SMN2 (0.44) MEN1KMT2AALDH1A1
SCHEMBL7728738 0.80 KDM4E (0.46) POLBMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed